side effects of coming off glp 1 Three major reviews commissioned by the World Health Organization find that while GLP-1 drugs can lead to substantial weight loss, researchers caution that most trials were funded by drugmakers, long-term safety data Long-term Success of GLP-1s Hinges

"So, when people come off a medication that they need to treat a chronic condition -- which the conditions of overweight and obesity are -- of course, rebound weight gain is possible, if not likely." In the United States, obesity affects nearly 42% of the population and is associated with over $170 billion in medical costs, according to the Centers for Disease Control and Prevention

After the 56-week treatment period, BMI standard deviation scores (BMI SDS) decreased by a mean of 0.23 in the liraglutide group, with no change in the placebo group

Is there a direct association between GLP-1RAs and SSIBs

From June 20 to 23, 2025, the 85th Scientific Sessions of the American Diabetes Association (ADA) convened in Chicago, USA

2 Material and methods This narrative literature review examines the use of SGLT-2 inhibitors and GLP-1 RAs in patients with T2DM and CVD

(2025) 'Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial' [Accessed 19 Jan